We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A T cell, its surface highly textured.

CAR T-Cell Therapy Impaired by Aging Immune Cell Metabolism

3D illustration of mitochondria showing inner membrane folds (cristae) crucial for cellular energy production.

Declining Mitochondrial Activity May Drive Obesity

A plastic model of a heart, illustrating heart research.

Structural Changes in the Aging Heart Protect Against Arrhythmias

Nano-engineered Thermoelectrics Enable Scalable, Compressor-Free Cooling

Gene Delivery Systems Designed for Cells in the Brain and Spinal Cord

Axolotl Limb Regeneration Code Cracked

News

Sigma-Aldrich Signs Exclusive Agreement with IsoSciences to Distribute Isotopically Labeled Bioactive Compounds

Under the terms of the agreement, IsoSciences will be the exclusive provider to Aldrich for their stable isotope products listed in the agreement for metabolic research.

OneWorld Health and BioFocus DPI Expand Diarrheal Disease Drug Discovery Collaboration

BioFocus DPI to performing a high-throughput, cell-based functional screen to identify potential new drugs for the treatment of diarrheal diseases.

Instituto de Medicina Molecular, Cenix BioScience, and Alnylam Discover new Pathway for Malaria Infection

New research using RNAi technologies published on the first molecular link between malaria and the host cholesterol uptake pathway.

Evotec Reports Start of Phase II Proof-of-Concept Quit Rate Study with EVT 302 and Results of Craving Study

The Phase II proof-of-concept study will investigate the effect of EVT 302 on the quit rate of patients who want to stop smoking.

Calando Pharmaceuticals Phase II Clinical Study Opens to Patient Enrollment

Company has initiated the United States trial evaluating the safety and efficacy of -101 in patients with platinum-sensitive ovarian cancer.

bioMerieux Gains Oncology and Theranostics Capabilities with the Acquisition of AviaraDx

bioMerieux now gains validated cancer biomarkers as well as capabilities in gene expression profiling in tissues for applications in oncology.

Pluristem Successfully Concludes Final Pre-Clinical Safety Studies with PLX-PAD in Preparation for Human Trials

Pluristem Therapeutics announce the successful conclusion of its pre-clinical studies utilizing PLX-PAD prior to the initiation of human clinical trials. PLX-PAD is Pluristem’s cellular product for the treatment of critical limb ischemia (CLI), the end phase of Peripheral Artery Disease (PAD).

Public Stem Cell Programme Has Potential to Save Lives

UK Health Secretary Alan Johnson opened a ground-breaking new centre in Nottingham offering a lifeline to thousands of people awaiting crucial stem cell transplants.

Epistem and Rottapharm Announce Positive Results

Epistem, the UK biotechnology company and Rottapharm Madaus, the multinational pharmaceutical company today announced that favourable results have been obtained with the prophylactic use of CR 3294 in a series of preclinical models for intestinal mucositis.

Enrolment Starts for Phase 2 Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter